Reported about 1 year ago
Due to a shortage of the antiviral drug Molnupiravir, the Taiwan Centers for Disease Control recommended physicians to prioritize prescribing Paxlovid and Remdesivir for COVID-19 patients. Elderly care institutions are worried that the strict conditions set by the CDC for prescribing antiviral drugs may result in a wave of deaths among infected elderly residents who are critically ill. Experts suggest relaxing the restrictions on publicly funded antiviral medications and returning to a market mechanism to allow patients the opportunity to self-fund medication. They also recommend prompt prescription of oral antiviral drugs for elderly individuals aged 65 and above with chronic illnesses to reduce the risk of severe COVID-19. Restrictions on the usage of Molnupiravir have resulted in challenges for elderly residents in care facilities with chronic diseases, as some are unable to directly use this drug despite needing it due to current regulations.
Source: YAHOO